GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Green Cross Medical Science Corp (XKRX:142280) » Definitions » Cyclically Adjusted Price-to-FCF

Green Cross Medical Science (XKRX:142280) Cyclically Adjusted Price-to-FCF : (As of Jun. 06, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Green Cross Medical Science Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Green Cross Medical Science Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Green Cross Medical Science's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Cross Medical Science Cyclically Adjusted Price-to-FCF Chart

Green Cross Medical Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Green Cross Medical Science Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Green Cross Medical Science's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Green Cross Medical Science's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Green Cross Medical Science's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Green Cross Medical Science's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Green Cross Medical Science's Cyclically Adjusted Price-to-FCF falls into.


;
;

Green Cross Medical Science Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Green Cross Medical Science's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Green Cross Medical Science's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-70.171/122.5900*122.5900
=-70.171

Current CPI (Mar. 2025) = 122.5900.

Green Cross Medical Science Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -98.626 100.051 -120.844
201509 -425.979 100.111 -521.630
201512 -15.323 100.220 -18.743
201603 228.182 100.561 278.168
201606 316.795 100.791 385.312
201609 168.094 101.461 203.099
201612 15.739 101.561 18.998
201703 120.106 102.851 143.157
201706 243.086 102.611 290.416
201709 -149.638 103.491 -177.254
201712 -38.212 102.991 -45.484
201803 -65.550 104.101 -77.192
201806 103.325 104.130 121.642
201809 -9.021 105.651 -10.467
201812 -533.271 104.351 -626.481
201903 47.410 104.491 55.622
201906 -88.210 104.881 -103.104
201909 -1.534 105.200 -1.788
201912 -234.624 105.121 -273.613
202003 -61.502 105.354 -71.564
202006 -367.649 105.112 -428.782
202009 -181.315 106.198 -209.302
202012 73.884 105.765 85.637
202103 -867.484 107.357 -990.570
202106 -283.271 107.579 -322.798
202109 -64.384 108.759 -72.572
202112 179.785 109.676 200.953
202203 660.014 111.848 723.402
202206 -205.332 114.072 -220.664
202209 75.120 114.715 80.277
202212 -172.992 115.179 -184.123
202303 174.373 116.507 183.477
202306 -124.932 117.182 -130.698
202309 -74.853 118.964 -77.135
202312 -51.033 118.837 -52.645
202403 98.445 120.123 100.467
202406 -99.668 120.007 -101.813
202409 59.783 120.861 60.638
202412 -43.217 121.135 -43.736
202503 -70.171 122.590 -70.171

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Green Cross Medical Science  (XKRX:142280) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Green Cross Medical Science Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Green Cross Medical Science's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Green Cross Medical Science Business Description

Traded in Other Exchanges
N/A
Address
107, Ihyeon-ro 30beon-gil, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 16924
Green Cross Medical Science Corp is a total medical device company. It is engaged in the blood glucose business, kidney hemodialysis business, and blood bag business with the application of its know-how in in-vitro diagnostics. The product portfolio offered by the organization includes diagnostic reagents, diagnostic instruments, blood bag, home medical devices, blood dialysis products and HbA1c/BGMS.

Green Cross Medical Science Headlines

No Headlines